Dr DALAC Sophie

Fiche personne


coordonnées

Hôpital François Mitterrand
14 rue Paul Gaffarel
BP 77908
21079 DIJON Cedex

03 80 29 33 36

Sophie.dalac@chu-dijon.fr

Territoire

Bourgogne

Statut

Hospitalier

Recherche

Expertises :
- Cancer:Peau
- Clinique:Dermatologie

Publications


Risk of irAEs in patients with autoimmune diseases treated by immune checkpoint inhibitors for stage III or IV melanoma: results from a matched case-control study.

Plaçais L, Dalle S, Dereure O, Trabelsi S, Dalac S, Legoupil D, Montaudié H, Arnault JP, De Quatrebarbes J, Saiag P, Brunet-Possenti F, Lesimple T, Maubec E, Aubin F, Granel-Brocard F, Grob JJ, Stoebner PE, Allayous C, Oriano B, Dutriaux C, Mortier L, Lebbe C

Ann Rheum Dis. 2022 07 4;:

Efficacy of sonic hedgehog inhibitors rechallenge, after initial complete response in recurrent advanced basal cell carcinoma: a retrospective study from the CARADERM database.

Bassompierre A, Dalac S, Dreno B, Neidhardt EM, Maubec E, Capelle C, Andre F, Behal H, Dziwniel V, Bens G, Leccia MT, Meyer N, Granel-Brocard F, Beylot-Barry M, Dereure O, Basset-Seguin N, Mortier L

ESMO Open. 2021 Oct 21;6(6):100284

Characterization of patients with advanced basal cell carcinoma progressing while receiving Hedgehog pathway inhibitors.

Monnet P, Herms F, Djermane M, Dalac S, Dereure O, Dréno B, Beylot-Barry M, Mortier L, Basset-Seguin N

Br J Dermatol. 2021 Oct 12;:

Voir plus